Treatment with lenalidomide and dexamethasone in patients with multiple myeloma and renal impairment

Meletios A Dimopoulos; Evangelos Terpos; Hartmut Goldschmidt; Adrían Alegre; Tomer M. Mark; Rubén Niesvizky

doi:10.1016/j.ctrv.2012.02.009

Related publications

Article2015

Continuous Lenalidomide and Low-Dose Dexamethasone for the Treatment of Patients with Newly Diagnosed Multiple Myeloma and Renal Impairment in the First Trial

Meletios A Dimopoulos, Matthew C. Cheung, Murielle Roussel, Ting Liu, Barbara Gamberi, Brigitte Kolb, Hans Günter Derigs, Hyeon‐Seok Eom, Karim Belhadj, Pascal Lenain, Richard van der Jagt, Sophie Rigaudeau, R. Hall, Arnaud Jaccard, Axel Tosikyan, Lionel Karlin, Jack W. Singer, Rik Schots, G. Chen, J Marek, Annette Ervin‐Haynes, Thierry Façon

Article2009

Lenalidomide and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma; Dosing of Lenalidomide According to Renal Function and Effect On Renal Impairment.

Meletios A Dimopoulos, Dimitrios Christoulas, Μαρία Ρούσσου, Efstathios Kastritis, Magdalini Migkou, Maria Gavriatopoulou, Μαρία Γκοτζαμανίδου, Marina Iakovaki, Charis Matsouka, Despina Mparmparoussi, Erasmia Psimenou, Irini Grapsa, Eleni Efstathiou, Evangelos Terpos

Article2010

Lenalidomide and dexamethasone for the treatment of refractory/relapsed multiple myeloma: dosing of lenalidomide according to renal function and effect on renal impairment

Meletios A Dimopoulos, Dimitrios Christoulas, Μαρία Ρούσσου, Efstathios Kastritis, Magdalini Migkou, Maria Gavriatopoulou, Charis Matsouka, Despoina Mparmparoussi, Erasmia Psimenou, Irini Grapsa, Eleni Efstathiou, Evangelos Terpos

Article2020

Pomalidomide, bortezomib, and dexamethasone (PVd) in lenalidomide (LEN)-pretreated relapsed refractory multiple myeloma: Subanalysis of patients with renal impairment in OPTIMISMM.

Fredrik Schjesvold, Meletios A Dimopoulos, Meral Beksaç, Albert Oriol, Jindriska Lindsay, Anna Marina Liberati, Mónica Galli, Paweł Robak, Katja Weisel, Alessandra Larocca, Münci Yağcı, Filiz Vural, Larry Anderson, Abraham S. Kanate, Eva Casal Mendez, Ruiyun Jiang, Shankar Srinivasan, Lara Grote, Tsvetan Biyukov, Paul G. Richardson

Article2017

Carfilzomib–lenalidomide–dexamethasone vs lenalidomide–dexamethasone in relapsed multiple myeloma by previous treatment

Meletios A Dimopoulos, A. Keith Stewart, Tamás Masszi, Ivan Špıčka, Albert Oriol, Roman Hájek, Laura Rosiñol, David S. Siegel, Georgi Mihaylov, Veselina Goranova‐Marinova, Péter Rajnics, Aleksandr Suvorov, Rubén Niesvizky, Andrzej Jakubowiak, Jesús F. San Miguel, Heinz Ludwig, Sunhee Ro, Sanjay Aggarwal, Philippe Moreau, Antonio Palumbo